This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Medical management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Drugs used in the medical management of peptic ulcer disease fall into three classes:

  • inhibition of acid secretion - proton pump inhibitors such as omeprazole
  • neutralization of acid - H2 antagonists, e.g. ranitidine 150 mg bd or 300 mg nocte for 4-8 weeks. Ranitidine is preferred because it has fewer side effects and drug interactions than cimetidine
  • increased mucosal resistance:
  • sucralfate - there is some concern about long-term use because of the drug's aluminium content. It may also reduce phenytoin absorption.
  • misoprostol

NICE have produced guidelines as to the management of dyspepsia in primary care (see linked items).


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.